John Breton
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Organic Chemistry top 10%
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
Papers in
-
- Natural product bioactivities and synthesis 4
-
- Inflammatory mediators and NSAID effects 7
- Co-authors
- Marie Chabot‐Fletcher (15 shared papers)Don E. Griswold (7 shared papers)John C. Lee (3 shared papers)Jerry L. Adams (5 shared papers)Ravi S. Garigipati (4 shared papers)Edward F. Webb (4 shared papers)Margaret E. Sorenson (4 shared papers)L. Sudre (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Journal of Investigative Dermatology (3 papers)Biochemical Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
John Breton
33 papers receiving 906 citations
Peers
Comparison fields: 5 of 94
- Pharmacology 130
- Organic Chemistry 238
- Toxicology 20
- Dermatology 49
- Immunology 110
Countries citing papers authored by John Breton
This map shows the geographic impact of John Breton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Breton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Breton more than expected).
Fields of papers citing papers by John Breton
This network shows the impact of papers produced by John Breton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Breton. The network helps show where John Breton may publish in the future.
Co-authors
The 25 scholars most cited alongside John Breton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 122 | |
| 2 | 1996 | 104 | |
| 3 | 2022 | 94 | |
| 4 | 1993 | 78 | |
| 5 | The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB. | 1997 | 53 |
| 6 | 2022 | 51 | |
| 7 | 2006 | 51 | |
| 8 | 2024 | 49 | |
| 9 | 2000 | 45 | |
| 10 | 1994 | 39 | |
| 11 | 2004 | 33 | |
| 12 | 1991 | 33 | |
| 13 | 1996 | 27 | |
| 14 | 1997 | 23 | |
| 15 | 1996 | 22 | |
| 16 | 1994 | 18 | |
| 17 | 1998 | 17 | |
| 18 | 1995 | 13 | |
| 19 | 1998 | 11 | |
| 20 | 2014 | 11 |
About John Breton
John Breton is a scholar working on Molecular Biology, Pharmacology, Oncology, Immunology and Epidemiology, having authored 35 papers that have together received 965 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Urinary Tract Infections Management (4 papers), Natural product bioactivities and synthesis (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Asthma and respiratory diseases (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Pharmacology (130 citations), Organic Chemistry (238 citations), Toxicology (20 citations), Dermatology (49 citations) and Immunology (110 citations). John Breton has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Marie Chabot‐Fletcher, Don E. Griswold, John C. Lee, Jerry L. Adams, Ravi S. Garigipati, Edward F. Webb, Margaret E. Sorenson, L. Sudre, Révital Rattenbach and Timothy F. Gallagher. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Investigative Dermatology, Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.